We have heard safety concerns regarding antibody testing for two weeks. It is the FDA's job to feret out the bad apples. But how did a company pocket $50 million on what you state is selling bad equipment?
Safety concerns are not the problem with the antibody based tests. Short sample and mis-sample are. Both lead to poor accuracy.
You need to brush up on these tests. Or as Dirk says, ask the self-proclaimed expert.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links